Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016
Primary Craniocervical Dystonia Presenting as a Respiratory Emergency
Neurol 68:388-389, Papapetropoulos,S.,et al, 2007
Ptosis as a Remote Effect of Therapeutic Botulinum Toxin B Injection
Neurol 59:1445-1447, Racette,B.A.,et al, 2002
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
Blepharospasm:Report of a Workshop
Neurol 46:1213-1218, Hallett,M.&Daroff,R.B., 1996
Dysphagia After Botulinum Toxin Injections for Spasmodic Torticolli:Clinical and Radiologic Findings
Neurol 42:1307-1310, Comella,C.L.,et al, 1992
Botulinum Toxin, Useful in Adult Onset Focal Dystonias
BMJ 305:1169-1170, Lees,A.J., 1992
Dopa-Responsive Dystonia:Long-Term Treatment Response and Prognosis
Neurol 41:174-181, Nygaard,T.G.,et al, 1991
Therapeutic Uses Of Botulinum Toxin
NEJM 324:1186-1194, Jankovic,J.&Brin,M.F., 1991
Botulinum Toxin Treatment in Spasmodic Torticollis
JNNP 53:640-643, Blacke,J.D.&Lees,A.J., 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Dopa Responsive Dystonia:A Treatable Condition Misdiagnosed as Cerebral Palsy
BMJ 298:1019-1020, Boyd,K.&Patterson,V., 1989
Blepharospasm:A Review of 264 Patients
JNNP 51:767-772, Grandas,F.,et al, 1988
Blepharospasm & Orofacial-Cervical Dystonia:Clinical & Pharmacological Findings in 100 Patients
Ann Neurol 13:402-411, Jankovic,J.,et al, 1983
Diagnosis of Treatable Wilson's Disease
NEJM 298:1347, Cartwright,G.E., 1978